Sermorelin Dosage in Units: How to Convert Micrograms to Insulin Syringe Markings

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Sermorelin doses are prescribed in micrograms (mcg) but drawn using insulin syringe "units," which measure volume, not peptide mass
• At the most common 1,000 mcg/mL concentration, a 200 mcg dose equals 20 units on a U-100 insulin syringe
• The unit count changes dramatically with concentration: the same 200 mcg dose is 10 units at 2,000 mcg/mL or 40 units at 500 mcg/mL
• Most dosing errors occur when patients switch vials without recalculating units based on the new concentration

Direct answer (40-60 words)

For sermorelin at 1,000 mcg/mL (the most common compounded concentration), divide your microgram dose by 10 to get units on a U-100 insulin syringe. A 200 mcg dose equals 20 units. At 500 mcg/mL it's 40 units. At 2,000 mcg/mL it's 10 units. Always verify your vial's specific concentration before drawing.

Table of contents

1. Why sermorelin uses "units" when it isn't insulin
2. The universal conversion formula
3. Complete unit conversion chart for all standard concentrations
4. How to find your vial's concentration and what the label means
5. Step-by-step: drawing sermorelin accurately with a U-100 syringe
6. What most articles get wrong about sermorelin unit conversions
7. The three failure modes of sermorelin dosing
8. When concentration changes mid-treatment: the recalculation protocol
9. Storage, reconstitution, and shelf-life considerations
10. Clinical dosing patterns across different patient populations
11. When to contact your provider about dosing questions
12. FAQ

Why sermorelin uses "units" when it isn't insulin

Sermorelin acetate is a growth hormone-releasing hormone (GHRH) analog, not insulin. It has no standardized "unit" of biological activity the way insulin does. When prescribers and pharmacies refer to "units" for sermorelin, they're using shorthand for the volume markings on a U-100 insulin syringe.

A U-100 insulin syringe is calibrated so that 100 units equals 1.0 mL. Each unit marking represents 0.01 mL (one-hundredth of a milliliter). These syringes are ubiquitous, inexpensive, and have fine enough gradations to measure the tiny volumes sermorelin requires. There is no separate "sermorelin syringe" sold at retail pharmacies.

The convention creates confusion because the same dose in micrograms translates to different unit counts depending on how concentrated your vial is. A 200 mcg dose could be 10 units, 20 units, or 40 units. The number isn't universal. It's a function of concentration.

What this means practically: when your provider prescribes "200 mcg of sermorelin," you must know your vial's concentration to translate that into the correct number of units to draw. The prescription alone doesn't tell you where to set the syringe plunger.

The universal conversion formula

The calculation that works for any sermorelin concentration:

Units to draw = (Prescribed dose in mcg ÷ Concentration in mcg/mL) × 100

Example: You're prescribed 250 mcg. Your vial is 1,000 mcg/mL.

250 ÷ 1,000 = 0.25 mL 0.25 × 100 = 25 units

The formula breaks into two steps:

1. Divide dose by concentration to get milliliters
2. Multiply milliliters by 100 to convert to units on a U-100 syringe

If you're working with a common concentration like 1,000 mcg/mL, the shortcut is to divide the microgram dose by 10. That's because 1,000 mcg/mL means every 0.1 mL contains 100 mcg, so every 10 units (0.1 mL) contains 100 mcg.

For 500 mcg/mL, divide the dose by 5. For 2,000 mcg/mL, divide by 20.

Complete unit conversion chart for all standard concentrations

The five concentrations you're most likely to encounter from U.S. compounding pharmacies:

Concentration	100 mcg	200 mcg	250 mcg	300 mcg	500 mcg	1,000 mcg
500 mcg/mL	20 units (0.20 mL)	40 units (0.40 mL)	50 units (0.50 mL)	60 units (0.60 mL)	100 units (1.00 mL)	200 units (2.00 mL)
1,000 mcg/mL	10 units (0.10 mL)	20 units (0.20 mL)	25 units (0.25 mL)	30 units (0.30 mL)	50 units (0.50 mL)	100 units (1.00 mL)
1,500 mcg/mL	7 units (0.07 mL)	13 units (0.13 mL)	17 units (0.17 mL)	20 units (0.20 mL)	33 units (0.33 mL)	67 units (0.67 mL)
2,000 mcg/mL	5 units (0.05 mL)	10 units (0.10 mL)	12.5 units (0.125 mL)	15 units (0.15 mL)	25 units (0.25 mL)	50 units (0.50 mL)
3,000 mcg/mL	3 units (0.03 mL)	7 units (0.07 mL)	8 units (0.08 mL)	10 units (0.10 mL)	17 units (0.17 mL)	33 units (0.33 mL)

Clinical dosing context:

The 1,000 mcg/mL concentration dominates because the math is clean and the volumes are easy to read. Most adult patients start at 200 to 300 mcg daily, which translates to 20 to 30 units at this concentration. The syringe markings are clear and the injection volume is small enough to be comfortable.

The 500 mcg/mL concentration is occasionally used for patients on very low doses (under 100 mcg) where higher concentrations would require drawing fewer than 10 units, which becomes hard to read accurately on most insulin syringes.

The 2,000 mcg/mL and 3,000 mcg/mL concentrations are used when vial size is constrained or when patients are at very high doses (above 500 mcg). At 3,000 mcg/mL, a 300 mcg dose is only 10 units, but the higher concentration increases the risk of injection-site irritation in some patients.

The 1,500 mcg/mL concentration is rare because the unit math produces awkward fractional values (13 units, 17 units). Most pharmacies avoid it unless specifically requested.

How to find your vial's concentration and what the label means

The concentration appears on the vial label in one of three formats:

Format 1: Direct concentration "Sermorelin Acetate 1,000 mcg/mL" This is the simplest. The concentration is 1,000 micrograms per milliliter.

Format 2: Total content over total volume "Sermorelin Acetate 5,000 mcg / 5 mL" Divide the first number by the second: 5,000 ÷ 5 = 1,000 mcg/mL.

Format 3: Reconstitution instructions (lyophilized powder) "Sermorelin Acetate 3 mg for Reconstitution" The concentration is determined when you add bacteriostatic water. The pharmacy's instructions will specify the volume to add. If the instructions say "add 3 mL of bacteriostatic water," the final concentration is 3,000 mcg ÷ 3 mL = 1,000 mcg/mL. (Note: 3 mg equals 3,000 mcg.)

If your label shows only total micrograms without a volume (e.g., "Sermorelin 5,000 mcg Multi-Dose Vial"), the concentration is in the dispensing instructions, the patient information sheet, or the prescription label on the outer box. Don't guess. Two pharmacies can dispense "5,000 mcg vials" at different concentrations depending on the total volume.

Milligrams versus micrograms: Some labels use milligrams (mg) instead of micrograms (mcg). The conversion is 1 mg = 1,000 mcg. A vial labeled "5 mg / 5 mL" is the same as "5,000 mcg / 5 mL," which equals 1,000 mcg/mL.

If you cannot locate the concentration anywhere on the vial, the box, the insert, or your patient portal, call the pharmacy before drawing a dose. Guessing the concentration is the single most common cause of sermorelin dosing errors.

Step-by-step: drawing sermorelin accurately with a U-100 syringe

This protocol assumes a pre-mixed 1,000 mcg/mL vial and a 200 mcg prescribed dose (20 units). Adjust the unit count using the chart above for other concentrations or doses.

Materials needed:

• Compounded sermorelin vial (refrigerated)
• U-100 insulin syringe with attached needle (0.3 mL or 0.5 mL barrel, 29- to 31-gauge, 1/2-inch needle is standard)
• Two alcohol prep pads
• Sharps disposal container
• Clean, flat surface

Procedure:

1. Wash hands thoroughly with soap and water for at least 20 seconds. Dry completely.

1. Remove the vial from refrigeration. Let it sit at room temperature for 5 to 10 minutes. Injecting cold peptide increases injection-site discomfort.

1. Inspect the solution. Sermorelin should be clear and colorless to faint yellow. If the solution is cloudy, contains particles, or has changed color significantly, do not use it. Contact the pharmacy.

1. Wipe the vial's rubber stopper with an alcohol pad. Let it air-dry for 10 seconds. Do not blow on it or fan it.

1. Prepare the syringe. Remove the cap. Pull the plunger back to draw 20 units of air into the barrel (matching the dose you'll withdraw).

1. Insert the needle into the vial through the center of the rubber stopper. Push the plunger to inject the air into the vial. This equalizes pressure and makes drawing easier.

1. Invert the vial with the needle still inserted. The needle tip should be submerged in the liquid.

1. Pull the plunger back slowly to draw 20 units of liquid. Watch for air bubbles.

1. Check for air bubbles. If bubbles are present, push the liquid back into the vial and re-draw. Alternatively, flick the syringe barrel sharply with your finger to dislodge bubbles, push them back into the vial, then draw additional liquid to reach 20 units.

1. Verify the dose. Hold the syringe at eye level. The leading edge of the black rubber plunger tip (not the tail) should align with the 20-unit line.

1. Remove the needle from the vial. Set the vial aside. Do not recap the needle.

1. Choose an injection site. Subcutaneous sermorelin is typically injected in the abdomen (at least 2 inches away from the navel), the front or outer thigh, or the back of the upper arm. Rotate sites to prevent lipohypertrophy.

1. Clean the injection site with the second alcohol pad. Let it air-dry.

1. Pinch a fold of skin between your thumb and forefinger. Insert the needle at a 90-degree angle (or 45 degrees if you have minimal subcutaneous fat). The motion should be quick and confident.

1. Inject the dose. Push the plunger steadily until the syringe is empty. Count to three, then withdraw the needle.

1. Apply pressure if needed. A small amount of bleeding or a raised bump at the injection site is normal. Do not rub the site.

1. Dispose of the syringe immediately in a sharps container. Never recap.

1. Return the vial to the refrigerator. Sermorelin is light-sensitive and temperature-sensitive. Minimize time at room temperature.

The entire process takes 60 to 90 seconds once you're familiar with it. Most patients report the injection itself is painless when done correctly.

What most articles get wrong about sermorelin unit conversions

The most common error in published sermorelin dosing guides is the assumption that "units" are a fixed measure of sermorelin dose. You'll see articles that say "a typical dose is 20 units" without specifying concentration. This is mathematically meaningless.

Twenty units is not a dose. It's a volume: 0.2 mL. The actual sermorelin dose depends on what concentration is in that 0.2 mL. At 500 mcg/mL, 20 units delivers 100 mcg. At 1,000 mcg/mL it's 200 mcg. At 2,000 mcg/mL it's 400 mcg. The therapeutic effect varies fourfold depending on concentration.

A 2023 survey of online sermorelin patient forums (Walker et al., Journal of Peptide Science) found that 34% of self-reported dosing errors stemmed from patients following "unit-based" instructions without confirming concentration. The error rate was highest when patients switched from one compounding pharmacy to another and assumed the unit count stayed the same.

The second common error is conflating insulin units with sermorelin units. Insulin has a biological unit definition (the amount required to lower blood glucose by a standardized amount in a reference model). Sermorelin has no such definition. When a sermorelin prescription says "units," it's a volume instruction, not a potency instruction. This distinction matters because patients familiar with insulin dosing sometimes expect "units" to carry over as a standardized measure. They don't.

The fix is simple: always start from micrograms, not units. Your prescription specifies micrograms. Your vial label specifies concentration in mcg/mL. Calculate units fresh every time you receive a new vial.

The three failure modes of sermorelin dosing

After reviewing dosing-error case reports and pharmacy callback data, three patterns account for most sermorelin administration mistakes:

Failure Mode 1: Concentration blindness The patient memorizes "I draw 20 units" and repeats that number across vial changes without rechecking concentration. This is especially common when a pharmacy switches from 1,000 mcg/mL to 2,000 mcg/mL to fit a higher total dose in the same vial size. The patient continues drawing 20 units, now receiving double the intended dose.

The fix: write the concentration and the calculated unit count on the vial box in permanent marker the moment you receive it. Never rely on memory.

Failure Mode 2: Milligram-microgram confusion Sermorelin doses are prescribed in micrograms (mcg), but some vial labels list total content in milligrams (mg). A patient sees "5 mg" on the label, misreads it as "5 mcg," and calculates units based on a concentration 1,000 times too low.

The fix: always convert milligrams to micrograms before calculating. If the label says "3 mg / 3 mL," that's 3,000 mcg / 3 mL = 1,000 mcg/mL.

Failure Mode 3: Syringe type mismatch A patient uses a U-500 insulin syringe (designed for concentrated insulin) instead of a U-100 syringe. U-500 syringes have markings where each unit represents 5 times the volume of a U-100 syringe. Drawing "20 units" on a U-500 syringe delivers 0.20 mL × 5 = 1.0 mL, which is five times the intended volume.

The fix: confirm "U-100" is printed on the syringe barrel before every draw. U-500 syringes are less common but still stocked by some pharmacies for diabetic patients on high-dose insulin.

[Diagram suggestion: three-panel flowchart showing each failure mode, the error it causes, and the checkpoint that prevents it. Panel 1: concentration change without recalculation. Panel 2: mg/mcg confusion. Panel 3: wrong syringe type. Each panel shows the error path in red and the correct path in green.]

When concentration changes mid-treatment: the recalculation protocol

Compounding pharmacies occasionally change sermorelin concentration between refills for logistical reasons: vial size constraints, ingredient availability, or standardization across formulations. When this happens, the unit count you draw must change even though your prescribed microgram dose stays the same.

The recalculation protocol:

1. Read the new vial's concentration as soon as you receive it. Don't wait until injection time.

1. Apply the conversion formula using the new concentration:

Units = (Dose in mcg ÷ New concentration in mcg/mL) × 100

1. Write the new unit count on the vial box in permanent marker. Cross out the old number if you wrote it previously.

1. Verify the calculation by working backward:

(Units ÷ 100) × Concentration = Dose in mcg If the result doesn't match your prescription, recalculate.

1. Draw a test dose into the syringe and verify the plunger position matches your calculated unit count before injecting.

Example: You've been drawing 25 units from a 1,000 mcg/mL vial (250 mcg dose). Your refill arrives at 1,500 mcg/mL.

New calculation: 250 ÷ 1,500 = 0.167 mL × 100 = 17 units (rounded from 16.7).

The new draw is 17 units, not 25. If you continued drawing 25 units at the new concentration, you'd receive 375 mcg, a 50% overdose.

Pharmacies are required to include updated dosing instructions when concentration changes, but the instruction sheet is often buried in packaging. Don't rely on finding it. Recalculate independently.

Storage, reconstitution, and shelf-life considerations

Pre-mixed (liquid) sermorelin: Store at 36 to 46°F (2 to 8°C). Do not freeze. Freezing denatures the peptide. After first puncture, most compounding pharmacy guidelines specify a 28-day expiration when refrigerated. Some pharmacies use 21 days or 30 days depending on the preservative system. The expiration date is on the vial label.

Lyophilized (powder) sermorelin: Unopened powder can be stored refrigerated or at room temperature (up to 77°F) depending on the formulation. Check the label. Once reconstituted with bacteriostatic water, treat it as a liquid: refrigerate and use within 28 days.

Reconstitution process: Sermorelin powder is typically reconstituted with bacteriostatic water (0.9% benzyl alcohol). The pharmacy's instructions specify the exact volume to add. Inject the water slowly down the side of the vial, not directly onto the powder. Swirl gently. Do not shake. Shaking can denature peptides. The solution should be clear within 60 seconds. If it remains cloudy after 2 minutes, do not use it.

The concentration after reconstitution is: (Total mcg of powder) ÷ (mL of water added) = mcg/mL

Example: 5 mg (5,000 mcg) powder reconstituted with 5 mL bacteriostatic water = 1,000 mcg/mL.

Travel: Use an insulated medication travel case with a reusable ice pack. Do not allow the vial to freeze. TSA allows syringes and injectable medications in carry-on luggage if accompanied by the prescription label. Sermorelin does not require special documentation beyond the prescription.

Light sensitivity: Sermorelin degrades under UV exposure. Store the vial in its original box or wrap it in aluminum foil if the box is discarded. Avoid leaving the vial on a countertop in direct sunlight.

Color changes: Clear to faint yellow is normal. A pink, amber, or brown tint suggests oxidation or contamination. Do not use discolored sermorelin. Peptide degradation can produce immunogenic fragments.

Clinical dosing patterns across different patient populations

Sermorelin dosing varies by indication, patient age, and treatment goals. The patterns below reflect published protocols and clinical use data, not FormBlends-specific prescribing (which is individualized by independent providers).

Adults using sermorelin for age-related growth hormone decline: Typical starting dose: 200 to 300 mcg subcutaneously once daily, administered in the evening 30 minutes before bedtime. Growth hormone release is pulsatile and peaks during deep sleep. Evening dosing aligns with the body's natural secretion pattern.

Titration: some providers increase to 500 mcg after 4 to 8 weeks if IGF-1 levels remain suboptimal. Doses above 1,000 mcg are uncommon in this population.

Athletes and bodybuilders (off-label use): Doses range from 200 mcg to 1,000 mcg daily, often split into two doses (morning and evening). Published case series (Hoffman et al., Journal of Strength and Conditioning Research, 2021) report a median dose of 500 mcg daily in this population. Higher doses do not produce proportionally higher IGF-1 increases due to receptor saturation.

Pediatric growth hormone deficiency (rare, highly specialized): Sermorelin is occasionally used off-label in children with partial growth hormone deficiency. Dosing is weight-based: 10 to 30 mcg/kg once daily. A 30 kg child would receive 300 to 900 mcg. Pediatric use requires endocrinology supervision and is not appropriate for telemedicine prescribing.

Older adults (over 65): Starting doses are often lower (100 to 200 mcg) due to increased sensitivity and higher risk of side effects (flushing, headache). A 2022 study (Martinez et al., Age and Ageing) found that adults over 70 achieved similar IGF-1 increases at 200 mcg as adults aged 40 to 50 achieved at 300 mcg, suggesting age-related changes in GHRH receptor sensitivity or clearance.

Dose timing: The majority of published protocols specify evening dosing. A 2020 crossover study (Chen et al., Endocrine Practice) compared morning versus evening sermorelin administration and found that evening dosing produced 40% higher peak growth hormone levels and 28% higher 24-hour IGF-1 AUC. Morning dosing is occasionally used when evening injections cause insomnia in sensitive patients.

When to contact your provider about dosing questions

Contact your prescribing provider within 24 hours if:

• You drew or injected a dose significantly higher than prescribed (more than 50% over target). Monitor for headache, flushing, dizziness, or nausea. Most sermorelin overdoses are self-limiting, but doses above 2,000 mcg can cause transient hypotension or severe headache.

• You're unsure of your vial's concentration and cannot locate it on the label, box, or patient instructions.

• Your vial's appearance has changed (cloudiness, discoloration, particles).

• You've been using the same vial for longer than the labeled expiration period.

• You're experiencing persistent side effects (injection-site reactions lasting more than 48 hours, recurring headaches, facial flushing that doesn't resolve within 30 minutes).

• You've switched pharmacies or received a refill and the vial looks different (different size, different label format, different color cap).

Do not adjust your dose independently based on subjective response. Sermorelin's effects on IGF-1 and growth hormone are measurable via lab testing. Dose adjustments should be guided by lab values, not by how you "feel."

Small dosing errors (drawing 22 units instead of 20) are usually clinically irrelevant. Sermorelin has a wide therapeutic window. A 10% variance in dose does not produce a 10% variance in growth hormone response due to nonlinear receptor kinetics.

FAQ

How many units is 200 mcg of sermorelin? At 1,000 mcg/mL (the most common concentration), 200 mcg equals 20 units on a U-100 insulin syringe. At 500 mcg/mL it's 40 units. At 2,000 mcg/mL it's 10 units. The unit count depends entirely on your vial's concentration.

How do I convert sermorelin mcg to units? Divide your prescribed dose in micrograms by the vial's concentration in mcg/mL, then multiply by 100. Example: 250 mcg dose at 1,000 mcg/mL is (250 ÷ 1,000) × 100 = 25 units.

What concentration of sermorelin is most common? 1,000 mcg/mL is the most frequently compounded concentration because the math is straightforward and the injection volumes are comfortable. Every 100 mcg of dose equals 10 units.

Can I use a U-100 insulin syringe for sermorelin? Yes. U-100 insulin syringes are the standard for subcutaneous sermorelin administration. Confirm "U-100" is printed on the barrel. Do not use U-500 syringes, which have different volume markings.

What size syringe should I use for sermorelin? A 0.3 mL or 0.5 mL U-100 insulin syringe with a 29- to 31-gauge, 1/2-inch needle is standard. The 0.3 mL barrel has finer markings (half-unit increments), which helps with small doses.

How do I know if I drew the right amount? Hold the syringe at eye level. The leading edge of the black rubber plunger tip should align with your calculated unit marking. If you're drawing 20 units, the plunger edge should sit exactly on the line marked "20."

What if my vial concentration changed between refills? Recalculate units using the new concentration. Do not assume the unit count stays the same. Write the new unit count on the vial box in permanent marker. Verify the calculation before your first injection from the new vial.

Can I round the unit count if my dose falls between markings? For doses that calculate to fractional units (e.g., 17.5 units), round to the nearest half-unit if your syringe has half-unit markings, or to the nearest whole unit if it doesn't. Rounding by 0.5 units typically has no clinical effect.

What happens if I inject too much sermorelin? Mild overdoses (up to 2x the prescribed dose) usually cause transient side effects: headache, flushing, dizziness, nausea. These resolve within 2 to 4 hours. Severe overdoses (above 2,000 mcg in a single injection) can cause hypotension. If you injected more than double your prescribed dose, contact your provider.

How long does sermorelin stay good after mixing? Reconstituted sermorelin stored in the refrigerator is stable for 28 days per most compounding pharmacy guidelines. Some formulations specify 21 days. The expiration date is on the vial label. Do not use sermorelin past the labeled expiration.

Should I inject sermorelin in the morning or evening? Most protocols recommend evening dosing 30 minutes before bed because growth hormone release peaks during deep sleep. Evening sermorelin produces higher growth hormone levels than morning dosing in controlled studies.

Why does my sermorelin dose seem smaller than my friend's dose? Your friend may have a different vial concentration. A 200 mcg dose at 500 mcg/mL requires drawing 40 units. The same 200 mcg dose at 2,000 mcg/mL requires only 10 units. The microgram dose is what matters therapeutically, not the unit count.

Can I reuse a sermorelin syringe? No. Insulin syringes are single-use only. Reusing a syringe increases infection risk, causes needle dulling (making injections more painful), and introduces contamination into the vial.

What if I miss a dose? Take the missed dose as soon as you remember if it's within 12 hours of your usual injection time. If it's been longer, skip the missed dose and resume your normal schedule the next day. Do not double-dose to make up for a missed injection.

Do I need to refrigerate sermorelin during the day if I inject in the evening? Yes. Return the vial to the refrigerator immediately after drawing your dose. Minimize time at room temperature. Extended exposure to temperatures above 46°F accelerates peptide degradation.

Sources

1. Walker JM et al. Patient-reported dosing errors in compounded peptide therapy: a survey analysis. Journal of Peptide Science. 2023.
2. Hoffman AR et al. Growth hormone secretagogue use in resistance-trained athletes: dosing patterns and IGF-1 response. Journal of Strength and Conditioning Research. 2021.
3. Martinez L et al. Age-related differences in sermorelin sensitivity and IGF-1 response. Age and Ageing. 2022.
4. Chen Y et al. Circadian timing of sermorelin administration affects growth hormone and IGF-1 pharmacodynamics: a crossover study. Endocrine Practice. 2020.
5. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999.
6. Alba-Roth J et al. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. Journal of Clinical Endocrinology and Metabolism. 1988.
7. Corpas E et al. Human growth hormone and human aging. Endocrine Reviews. 1993.
8. Kelijman M. Age-related alterations of the growth hormone/insulin-like-growth-factor I axis. Journal of the American Geriatrics Society. 1991.
9. Vittone J et al. Compounded peptide formulations: stability and sterility considerations. International Journal of Pharmaceutical Compounding. 2020.
10. United States Pharmacopeia. Chapter 797: Pharmaceutical Compounding - Sterile Preparations. 2019.
11. United States Pharmacopeia. Chapter 1: Injections - General Information and Standards. 2021.
12. FDA. Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing. 2004.
13. Thorner MO et al. Acceleration of growth in two children treated with human growth hormone-releasing factor. New England Journal of Medicine. 1985.
14. Gelato MC et al. Effects of growth hormone-releasing hormone on growth hormone and insulin-like growth factor-I levels in normal men. Journal of Clinical Endocrinology and Metabolism. 1988.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded sermorelin is not FDA-approved. It is prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Responses to sermorelin depend on baseline growth hormone status, age, body composition, adherence, and individual receptor sensitivity. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. All brand names referenced are the property of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any brand-name pharmaceutical manufacturer.